Antibiotic Nanoparticles-Loaded Wound Dressings Against Pseudomonas aeruginosa’s Skin Infection: A Systematic Review
Metadatos
Mostrar el registro completo del ítemAutor
Quiñones Vico, María Isabel; Ubago Rodríguez, Ana Dolores; Fernández González, Ana; Sanabria de la Torre, Raquel; Sierra Sánchez, Álvaro; Montero Vílchez, Trinidad; Sánchez Díaz, Manuel; Arias Mediano, José Luis; Arias Santiago, Salvador AntonioEditorial
Taylor and Francis Group
Materia
hydrogel skin infection wound dressing
Fecha
2024-08-02Referencia bibliográfica
Quiñones Vico, M.I. et. al. 2024;19:7895-7926. [https://doi.org/10.2147/IJN.S469724]
Patrocinador
predoctoral fellowship (FPU19/05455, BOE 22 October 2019) from the Ministry of Science, Innovation and Universities of Spain; Biomedicine program at the University of Granada; Andalusian Regional Government (PIGE-0242-2019) and the Carlos III Health Institute (PI17/02083)Resumen
Pseudomonas aeruginosa (P. aeruginosa) is a common nosocomial pathogen that can cause severe infections in critically
ill patients. Due to its resistance to multiple drugs, it is challenging to treat, which can result in serious illness and death. Conventional
treatments for infected wounds often involve the topical or systemic application of antibiotics, which can lead to systemic toxicity and
the development of drug resistance. The combination of wound dressings that promote wound healing with nanoparticles (NPs)
represents a revolutionary strategy for optimizing the safety and efficacy of antibiotics. This review assesses a systematic search to
identify the latest approaches where the evaluation of wound dressings loaded with antibiotic NPs is conducted. The properties of NPs,
the features of wound dressings, the antimicrobial activity and biocompatibility of the different strategies are analyzed. The results
indicate that most research in this field is focused on dressings loaded with silver NPs (57.1%) or other inorganic materials (22.4%).
Wound dressings loaded with polymeric NPs and carbon-based NPs represent 14.3% and 6.1% of the evaluated studies, respectively.
Nevertheless, there are no clinical trials that have evaluated the efficacy of NPs-loaded wound dressings in patients. Further research is
required to ensure the safety of these treatments and to translate the findings from the bench to the bedside.